BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38452437)

  • 1. Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.
    Arenare L; Di Liello R; De Placido P; Gridelli C; Morabito A; Pignata S; Nuzzo F; Avallone A; Maiello E; Gargiulo P; Schettino C; Gravina A; Gallo C; Chiodini P; Di Maio M; Perrone F; Piccirillo MC
    ESMO Open; 2024 Mar; 9(3):102941. PubMed ID: 38452437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
    Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
    J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
    Di Maio M; Gallo C; Leighl NB; Piccirillo MC; Daniele G; Nuzzo F; Gridelli C; Gebbia V; Ciardiello F; De Placido S; Ceribelli A; Favaretto AG; de Matteis A; Feld R; Butts C; Bryce J; Signoriello S; Morabito A; Rocco G; Perrone F
    J Clin Oncol; 2015 Mar; 33(8):910-5. PubMed ID: 25624439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.
    Sutherland A; Naessens K; Plugge E; Ware L; Head K; Burton MJ; Wee B
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012555. PubMed ID: 30246876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.
    Zikos E; Coens C; Quinten C; Ediebah DE; Martinelli F; Ghislain I; King MT; Gotay C; Ringash J; Velikova G; Reeve BB; Greimel E; Cleeland CS; Flechtner H; Taphoorn MJ; Weis J; Schmucker-von Koch J; Sprangers MA; Bottomley A;
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26714759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
    Ooki A; Morita S; Tsuji A; Iwamoto S; Hara H; Tanioka H; Satake H; Kataoka M; Kotaka M; Kagawa Y; Nakamura M; Shingai T; Ishikawa M; Miyake Y; Suto T; Hashiguchi Y; Yabuno T; Ando M; Sakamoto J; Yamaguchi K
    Cancer Med; 2020 Dec; 9(24):9419-9430. PubMed ID: 33222406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.
    Donovan KA; Donovan HS; Cella D; Gaines ME; Penson RT; Plaxe SC; von Gruenigen VE; Bruner DW; Reeve BB; Wenzel L
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
    Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
    Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How best to assess the quality of life in long-term survivors after surgery for NSCLC? Comparison between clinical predictors and questionnaire scores.
    Sterzi S; Cesario A; Cusumano G; Corbo G; Lococo F; Biasotti B; Lapenna LM; Magrone G; Dall'armi V; Meacci E; Porziella V; Bonassi S; Margaritora S; Granone P
    Clin Lung Cancer; 2013 Jan; 14(1):78-87. PubMed ID: 22607778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of overall quality of life in preterminal cancer patients.
    Beijer S; Kempen GI; Pijls-Johannesma MC; de Graeff A; Dagnelie PC
    Int J Cancer; 2008 Jul; 123(1):232-5. PubMed ID: 18412247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise interventions for adults with cancer receiving radiation therapy alone.
    Trommer M; Marnitz S; Skoetz N; Rupp R; Niels T; Morgenthaler J; Theurich S; von Bergwelt-Baildon M; Baues C; Baumann FT
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013448. PubMed ID: 36912791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
    Marino D; Baratelli C; Guida G; Turco CGC; Lacidogna G; Sperti E; Vignani F; De Luca E; Zichi C; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M
    Recenti Prog Med; 2020 Dec; 111(12):740-748. PubMed ID: 33362171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.
    Pirri C; Bayliss E; Trotter J; Olver IN; Katris P; Drummond P; Bennett R
    Support Care Cancer; 2013 Mar; 21(3):735-48. PubMed ID: 22976921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Range and consistency of gastrointestinal outcomes reported in peritoneal dialysis trials: A systematic review.
    Hayat A; Walker RC; Viecelli AK; Manera KE; Jaure A; Krishnasamy R; Pascoe EM; Cho Y; Johnson DW
    Perit Dial Int; 2023 Jul; 43(4):315-323. PubMed ID: 36127835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
    Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
    Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.